This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Shanghai Pharmaceuticals Holding Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sijie Shu and WEE1 Kinase Inhibitor Research.
Introduction
Sijie Shu is an inventor associated with Shanghai, China, and Shanghai Pharmaceuticals Holding Co., Ltd. His patent work concerns a pyrazolone-fused pyrimidine compound developed for potential pharmaceutical applications.
Latest Patents
The supplied information identifies one patent associated with Shu: “Pyrazolone-fused pyrimidine compound, preparation method for same and applications thereof.” The patent describes a compound represented by formula (II), methods for preparing it, and its applications. According to the provided description, the compound has improved inhibitory activity against WEE1 kinase. Shu is credited with 1 patent in the information provided.
Career Highlights
Shu’s documented patent contribution focuses on medicinal chemistry and the development of compounds targeting WEE1 kinase. The supplied information associates him with Shanghai Pharmaceuticals Holding Co., Ltd.
Collaborations
Lin Zhang and Qian Wang are identified as Shu’s coworkers. The information provided does not specify their roles in the patent or the extent of their collaboration.
Conclusion
Sijie Shu’s listed patent highlights his work on a pyrazolone-fused pyrimidine compound with reported WEE1 kinase inhibitory activity, connecting his invention to pharmaceutical research at Shanghai Pharmaceuticals Holding Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile